Skip to main content
. 2021 Nov 8;9:779432. doi: 10.3389/fcell.2021.779432

FIGURE 4.

FIGURE 4

GSDMD silencing alleviated myocardial cell injury induced by LPS. (A and E) CCK-8 assay was applied to measure cell viability of each group. (B and F) LDH release in supernatants of each group. (C and G) The level of IL-1β in supernatants of each group. (D and H) Expressions of GSDMD and GSDMD-NT protein in H9c2 cells and primary cardiomyocytes were measured by Western blotting analysis. The results were normalized to the expression of GAPDH. The data are expressed as the mean ± SD (n = 3). (I) After transfected with siRNA of Gsdmd, H9c2 cells were treated with LPS plus nigericin to establish the myocardial injury model. Expressions of GSDMD and GSDMD-NT protein in H9c2 cells were measured by Western blotting analysis (n = 3). (J) CCK-8 assay was applied to measure cell viability of each group. (K) LDH release in supernatants of each group. The data are expressed as the mean ± SD (n = 3). **p < 0.01, ***p < 0.001.